News & Updates

Once-a-week treatment with ecnoglutide demonstrates superiority over placebo, with sustained reductions in body weight and improvements in cardiometabolic indexes among adults with overweight or obesity, reports a study presented at ADA 2025.

Researchers from the University of Hong Kong (HKU) have identified lithium level thresholds associated with risks of hypothyroidism, hyperthyroidism, and stage ≥3 chronic kidney disease (CKD). This provides empirical evidence that can facilitate the development of clinical guidelines for lithium treatment in bipolar disorder.